PROCEPT BioRobotics Corp
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $308.1M | $224.5M | $136.2M | $75.0M | $34.5M |
| Gross profit | $196.2M | $137.1M | $71.0M | $37.1M | $15.9M |
| Operating income | -$103.9M | -$96.6M | -$109.2M | -$80.7M | -$54.2M |
| Operating expenses | $300.1M | $233.7M | $180.2M | $117.8M | $70.0M |
| Cost of revenue | $111.8M | $87.4M | $65.1M | $37.9M | $18.6M |
| Cash from operations | -$49.0M | -$99.2M | -$108.0M | -$80.4M | -$57.3M |
| Capital expenditure | $9.4M | $4.4M | $25.2M | $2.7M | $592,000 |
| Free cash flow | -$58.3M | -$103.6M | -$133.2M | -$83.0M | -$57.9M |
| Impairments | — | — | — | — | $0 |
| Total assets | $508.1M | $534.0M | $404.7M | $309.3M | $337.0M |
| Total liabilities | $142.2M | $131.8M | $124.0M | $112.3M | $69.9M |
| Total debt | $52.0M | $52.0M | $52.0M | $52.0M | $50.0M |
Shares outstanding 56.9M · Free float 91.4%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.